Clinica
Genentech, Plexxikon win US OK for melanoma Rx, companion Dx
18 August 2011
Donna Young
Not a subscriber ? Request a FREE Trial
Subscribe to Clinica
RELATED CONTENT
NEWS
Clinica News
- Roche/Plexxikon's Zelboraf secures EU approval for personalised skin cancer medicine
- US FDA lays out ambitious goals for driving drug and device innovation, but funding hazy
- Roche sees Dx unit outperform market, but hit by strong Swiss franc
- Companion diagnostics trend will make Rx look at in-house Dx anew
Other Informa News
EVENTS
